The emerging resistance to cephalosporins and carbapenems in gram-negative pathogens poses significant health challenges and increased treatment failures. The development and evaluation of novel thera

NIAID Data Ecosystem30

In Vitro Activities of the Everninomicin SCH 27899 and Other Newer Antimicrobial Agents against Borrelia burgdorferi

抗菌药物体外活性

莱姆病病原体药敏测试

The in vitro activity of the everninomicin antibiotic SCH 27899 against 17 isolates of Borrelia spp. was investigated. MICs ranged from 0.06 to 0.5 μg/ml. Time-kill studies with the B31 strain of B. b

PubMed Central20

Minimum Bactericidal Concentrations.

抗菌药物评价

体外实验

Bactericidal activity of free and liposomal formulations against susceptible P. aeruginosa ATCC 27853 strain was carried out in broth alone or in presence of DNA/F-actin/LPS/LTA at a final concentrati

Figshare2015-12-02 更新50

In vitro antibacterial activities of AMPs and antibiotics against MDR C. perfringens strains.

多重耐药菌研究

抗菌药物体外活性

In vitro antibacterial activities of AMPs and antibiotics against MDR C. perfringens strains.

Figshare2017-09-22 更新20